1. Home
  2. CING vs AQMS Comparison

CING vs AQMS Comparison

Compare CING & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • AQMS
  • Stock Information
  • Founded
  • CING 2012
  • AQMS 2014
  • Country
  • CING United States
  • AQMS United States
  • Employees
  • CING N/A
  • AQMS N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • AQMS Metal Fabrications
  • Sector
  • CING Health Care
  • AQMS Industrials
  • Exchange
  • CING Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • CING 13.1M
  • AQMS 13.7M
  • IPO Year
  • CING 2021
  • AQMS 2015
  • Fundamental
  • Price
  • CING $4.33
  • AQMS $1.52
  • Analyst Decision
  • CING Strong Buy
  • AQMS Strong Buy
  • Analyst Count
  • CING 4
  • AQMS 3
  • Target Price
  • CING $30.67
  • AQMS $21.00
  • AVG Volume (30 Days)
  • CING 97.0K
  • AQMS 73.8K
  • Earning Date
  • CING 05-07-2025
  • AQMS 05-14-2025
  • Dividend Yield
  • CING N/A
  • AQMS N/A
  • EPS Growth
  • CING N/A
  • AQMS N/A
  • EPS
  • CING N/A
  • AQMS N/A
  • Revenue
  • CING N/A
  • AQMS N/A
  • Revenue This Year
  • CING N/A
  • AQMS N/A
  • Revenue Next Year
  • CING N/A
  • AQMS $550.00
  • P/E Ratio
  • CING N/A
  • AQMS N/A
  • Revenue Growth
  • CING N/A
  • AQMS N/A
  • 52 Week Low
  • CING $1.80
  • AQMS $1.33
  • 52 Week High
  • CING $20.83
  • AQMS $11.40
  • Technical
  • Relative Strength Index (RSI)
  • CING 57.77
  • AQMS 36.08
  • Support Level
  • CING $4.03
  • AQMS $1.42
  • Resistance Level
  • CING $4.44
  • AQMS $1.54
  • Average True Range (ATR)
  • CING 0.29
  • AQMS 0.16
  • MACD
  • CING 0.04
  • AQMS -0.01
  • Stochastic Oscillator
  • CING 74.38
  • AQMS 11.11

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: